In animal models finerenone reduced the expression of genes encoding monocyte chemoattractant protein-1, matrix metalloproteinase-2 and plasminogen activator inhibitor-1 (related to tissue remodelling and fibrosis) in the kidney, and additionally demonstrated beneficial immunomodulatory effects [73]
The Phase 3 OASIS-4 trial compared a 25 mg once-daily pill to placebo alongside lifestyle counseling and showed significant improvements in blood pressure, cholesterol, blood sugar and inflammation
GLP-1 Drugs and Triathlon Performance: What Ozempic Really Does to Athletes May 15, 2026 GLP-1 medications like semaglutide (Ozempic, Wegovy) can significantly affect triathlon performance by suppressing appetite, slowing gastric emptying and increasing the risk of muscle loss and chronic under-fuelling
By promoting significant and sustained weight loss, GLP-1 metabolic health Chicago treatments like Zepbound and Wegovy directly combat several components of metabolic syndrome simultaneously
However, semaglutide slows the rate at which food leaves the stomach, prolonging its stay there